Dr.Finance (WAR:DRF) Moat Score: 0/10 (As of Jul. 03, 2026)


WAR:DRF Dr.Finance SA WAR:DRF
41 GF Score
Price zł1.07
GF Value zł0.50
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Dr.Finance Moat Score?

Dr.Finance has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Dr.Finance has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Dr.Finance might have No Moat - No discernible moat.


Dr.Finance  (WAR:DRF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Dr.Finance Moat Score Related Terms

WAR:DRF
41GF Score
Dr.Finance SA WAR:DRF
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Dr.Finance (WAR:DRF) Overvalued in 2026?

Based on GuruFocus' analysis, Dr.Finance stock appears to be overvalued. The current stock price of zł1.07 is trading 114% above its estimated GF Value™ of zł0.50. GuruFocus considers Dr.Finance to be Significantly Overvalued.

Key valuation signals for WAR:DRF:

  • Moat Score: 0
  • GF Value™: zł0.50 vs. price of zł1.07 (114% above fair value)
  • GF Score™: 41/100 with 3 warning signs

No single metric tells the full story. See the WAR:DRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dr.Finance Business Description

Address ul. Braniborska 65/12, Wroclaw, POL, 53-680
Dr.Finance SA is a financial intermediary in the sale of loans and other financial products. It operates in the business of Working capital loans, Investment loans, Leasing, and Factoring.
41GF Score

Get the complete analysis for WAR:DRF

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł1.07
Price
zł0.50
GF Value